Bimzelx 160 mg, solution injectable en stylo prérempli
7680686120013
CH-68612
Lösung
Associated product:
BIMZELX 160 mg/ml stylo pré (emb individ) 1 ml
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Injektor(en), vorgefüllt/Pen
- Galenic form
- Lösung
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
bimekizumabum
|
160.0 MG | Substance | Wirkstoff (Principe actif) |
|
glycinum
|
- | Substance | HNIDK |
|
natrii acetas trihydricus
|
- | Substance | HNIDK |
|
acidum aceticum glaciale
|
- | Substance | HNIDK |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
0.45 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 1012.55
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/12/2024
Authorization holder
UCB-Pharma SA
1630 Bulle
Authorization information
- Swissmedic authorization number
- 68612
- Drug name
- Bimzelx, solution injectable en stylo prérempli
- Galenic form
- INLFP
- ATC Code
- L04AC21
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 27/10/2022
- Authorization expiration date
- 26/10/2027
- IT Number
- 07.15.0.
- Domain
- Human medicine
Package details
- Description (FR)
- BIMZELX 160 mg/ml stylo pré (emb individ) 1 ml
- Description (DE)
- BIMZELX 160 mg/ml Fertpen (Einzelpackung) 1 ml
- Market launch
- 27/10/2022
- Narcotic (BTM)
- No